• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

The natural history of multiple sclerosis: a geographically based study. 2. Predictive value of the early clinical course.

作者信息

Weinshenker B G, Bass B, Rice G P, Noseworthy J, Carriere W, Baskerville J, Ebers G C

机构信息

Department of Clinical Neurological Sciences, University of Western Ontario, London, Canada.

出版信息

Brain. 1989 Dec;112 ( Pt 6):1419-28. doi: 10.1093/brain/112.6.1419.

DOI:10.1093/brain/112.6.1419
PMID:2597989
Abstract

Controversy exists regarding the predictive value of the early clinical course of multiple sclerosis (MS). Three parameters often considered are the attack rate, the first interattack interval and the rate at which disability develops in the early years of the disease. We have recorded the time to reach successive levels of disability defined by the Kurtzke Disability Status Scale (DSS) in 1,099 MS patients followed at University Hospital, London, Canada between 1972 and 1984. Our population is particularly suitable because of its size, the high degree of ascertainment of cases in the community, and the regular follow-up provided. Life table analysis was used to compare survival in patients stratified according to the above three parameters using DSS 6 as end point. Significant differences were evident in the survival distributions. Despite the extensive interindividual variation in the rate at which disability developed, the early course of MS may be useful in determining the relative risk of rapid progression.

摘要

相似文献

1
The natural history of multiple sclerosis: a geographically based study. 2. Predictive value of the early clinical course.
Brain. 1989 Dec;112 ( Pt 6):1419-28. doi: 10.1093/brain/112.6.1419.
2
The natural history of multiple sclerosis: a geographically based study. I. Clinical course and disability.多发性硬化症的自然史:一项基于地域的研究。I. 临床病程与残疾情况
Brain. 1989 Feb;112 ( Pt 1):133-46. doi: 10.1093/brain/112.1.133.
3
The natural history of multiple sclerosis: a geographically based study. 5. The clinical features and natural history of primary progressive multiple sclerosis.多发性硬化症的自然史:一项基于地域的研究。5. 原发性进行性多发性硬化症的临床特征及自然史。
Brain. 1999 Apr;122 ( Pt 4):625-39. doi: 10.1093/brain/122.4.625.
4
The natural history of multiple sclerosis: a geographically based study 9: observations on the progressive phase of the disease.多发性硬化症的自然史:一项基于地域的研究9:关于疾病进展期的观察
Brain. 2006 Mar;129(Pt 3):584-94. doi: 10.1093/brain/awh721. Epub 2006 Jan 9.
5
Age at disability milestones in multiple sclerosis.多发性硬化症中达到残疾里程碑的年龄。
Brain. 2006 Mar;129(Pt 3):595-605. doi: 10.1093/brain/awh714. Epub 2006 Jan 16.
6
The natural history of multiple sclerosis: a geographically based study. 3. Multivariate analysis of predictive factors and models of outcome.
Brain. 1991 Apr;114 ( Pt 2):1045-56. doi: 10.1093/brain/114.2.1045.
7
The natural history of multiple sclerosis: a regional study with some longitudinal data.多发性硬化症的自然史:一项包含部分纵向数据的区域研究。
J Neurol Neurosurg Psychiatry. 1992 May;55(5):341-6. doi: 10.1136/jnnp.55.5.341.
8
The natural history of multiple sclerosis: a geographically based study. 4. Applications to planning and interpretation of clinical therapeutic trials.
Brain. 1991 Apr;114 ( Pt 2):1057-67. doi: 10.1093/brain/114.2.1057.
9
The natural history of multiple sclerosis.多发性硬化症的自然病史。
Can J Neurol Sci. 1987 Aug;14(3):255-61. doi: 10.1017/s0317167100026573.
10
Change in disability profile and quality of life in multiple sclerosis patients: a five-year longitudinal study using the Multiple Sclerosis Impact Profile (MSIP).多发性硬化症患者残疾状况和生活质量的变化:一项使用多发性硬化症影响量表(MSIP)的五年纵向研究。
Mult Scler. 2012 May;18(5):654-61. doi: 10.1177/1352458511423935. Epub 2011 Sep 30.

引用本文的文献

1
Influence of age and sex on presymptomatic phases of neurodegenerative diseases: Focus on multiple sclerosis and Alzheimer's disease.年龄和性别对神经退行性疾病症状前期的影响:聚焦于多发性硬化症和阿尔茨海默病。
Rev Neurol (Paris). 2025 Aug 6. doi: 10.1016/j.neurol.2025.06.015.
2
Racial Inequities, Multiple Sclerosis, and Implementation of a Novel Treatment Algorithm at the Health System Level.种族不平等、多发性硬化症以及卫生系统层面新型治疗算法的实施
Neurology. 2025 May 27;104(10):e213607. doi: 10.1212/WNL.0000000000213607. Epub 2025 Apr 21.
3
EARLY ONSET OF MULTIPLE SCLEROSIS - CLINICAL FEATURES.
多发性硬化症的早期发病——临床特征
Acta Clin Croat. 2024 Apr;63(1):23-28. doi: 10.20471/acc.2024.63.01.3.
4
New-Onset Multiple Sclerosis in Pregnancy: Diagnostic Approaches and Treatment Dilemmas.妊娠期新发多发性硬化症:诊断方法与治疗困境
Cureus. 2024 Nov 28;16(11):e74685. doi: 10.7759/cureus.74685. eCollection 2024 Nov.
5
Picturing the Multiple Sclerosis Patient Journey: A Symptomatic Overview.描绘多发性硬化症患者的病程:症状概述
J Clin Med. 2024 Sep 25;13(19):5687. doi: 10.3390/jcm13195687.
6
Exploring the therapeutic potential of autologous hematopoietic stem cell transplantation in progressive multiple sclerosis-a systematic review.探索自体造血干细胞移植治疗进展性多发性硬化症的潜力——系统评价。
Eur J Neurol. 2024 Dec;31(12):e16427. doi: 10.1111/ene.16427. Epub 2024 Aug 5.
7
Long-Term Disability Outcomes in Relapsing-Remitting Multiple Sclerosis Patients: Impact of Clinical and Demographic Factors on Disease Progression.复发缓解型多发性硬化症患者的长期残疾结局:临床和人口统计学因素对疾病进展的影响
J Clin Med. 2024 Mar 21;13(6):1813. doi: 10.3390/jcm13061813.
8
Development of a predictive model for predicting disability after optic neuritis: a secondary analysis of the Optic Neuritis Treatment Trial.视神经炎后残疾预测模型的开发:视神经炎治疗试验的二次分析
Front Neurol. 2024 Jan 8;14:1326261. doi: 10.3389/fneur.2023.1326261. eCollection 2023.
9
Multiple sclerosis: time for early treatment with high-efficacy drugs.多发性硬化症:是时候用高效药物进行早期治疗了。
J Neurol. 2024 Jan;271(1):105-115. doi: 10.1007/s00415-023-11969-8. Epub 2023 Oct 18.
10
A Real-World Experience of Azathioprine Versus First-Line Disease-Modifying Therapy in Relapsing-Remitting Multiple Sclerosis-A Prospective Cohort Study.硫唑嘌呤与一线疾病修正疗法治疗复发缓解型多发性硬化症的真实世界经验——一项前瞻性队列研究
Brain Sci. 2023 Aug 27;13(9):1249. doi: 10.3390/brainsci13091249.